Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Plan sponsors have four main tools to drive biosimilar adoption: preferred formulary placement (putting the biosimilar on a lower tier and the reference drug on a higher tier), step therapy for new patients, automatic substitution where state law permits, and formulary exclusion of the reference drug entirely
Understanding this difference prevents confusion during pharmacy purchases
The oral formulation uses similar delayed release technology
Lets break down the key components of IV therapy: hydration, vitamin infusions, and injections
US$ 21.87
US$ 24.67
US$ 25.06
US$ 29.79
US$ 20.00
US$ 26.98
US$ 27.83
US$ 29.38
US$ 22.49
US$ 29.95
